Latest Market News

Aussie Broadband has reaffirmed its FY27 underlying EBITDA guidance of $205 million to $215 million after adding more than 193,000 broadband connections since June. The company says major customer migrations are nearing completion, shifting the focus from scale-building to integration and productivity.

Zoono Group is seeking up to A$1.61 million from a non-renounceable rights issue after completing a separate A$250,000 placement, with its offer document warning of material uncertainty around going concern. The funds are intended to support shelf-life extension projects, intellectual property and working capital, but investors face dilution and an unresolved legal case.

Hydration Pharmaceuticals is asking eligible shareholders for up to A$1.43 million in fresh capital as it funds the next phase of its turnaround. The non-renounceable offer comes with free options, but is neither underwritten nor subject to a minimum subscription.

FAR’s remaining value is tied largely to Woodside’s Sangomar production and oil prices, with up to US$19.8 million still potentially payable after a US$23.7 million provisional receipt. The oil and gas company ended September with US$1.73 million in unaudited cash and no exploration expenditure.

Sunrise Energy Metals has completed key Syerston engineering work and received a conditional commitment for up to US$400 million in long-term debt from the U.S. Office of Strategic Capital. The project’s revised scope now carries an estimated A$450 million to A$475 million capital cost, while the proposed Nasdaq redomiciliation remains subject to multiple approvals.

Objective Corporation delivered 9% revenue growth and a 5% lift in net profit for FY2026, but the loss of a long-running Defence agreement and a separate NHVR contract will pressure recurring revenue in the year ahead. Management expects adjusted EBITDA of at least $40 million in FY2027 as it keeps investing in AI, sales capacity and potential acquisitions.

MaxiPARTS has delivered a sharp lift in first-quarter operating profit despite modest revenue growth, while its newly acquired Air Brake Systems business is set to contribute for most of FY27. The company has reiterated expectations for further earnings improvement and increased capital returns.

PeopleIN improved underlying earnings and reduced leverage in FY26 despite a statutory loss, as Queensland’s infrastructure demand drove a sharp recovery in its core workforce division. The company is now betting that a leaner portfolio, Infrawork’s trans-Tasman labour channel and Brisbane 2032-related work can sustain the upturn.

IPD Group closed FY26 with record revenue and earnings, a higher fully franked dividend and leverage of about 0.3 times underlying EBITDA. The electrical infrastructure provider enters FY27 with its data centre pipeline and Platinum Cables integration carrying much of the growth narrative.

Monash IVF Group’s underlying NPAT fell 41% to A$16.1 million in FY26, missing its recently reduced guidance as softer Australian IVF activity outweighed international growth. A second-half market-share recovery, lower planned capital spending and a new productivity program now carry the FY27 investment case.

X2M Connect has secured 60-day exclusivity over a Queensland site for a planned 10MW AI-enabled data centre, with development approval and 2.5MW of grid capacity already in place. The estimated $250 million project could add delivery revenue, recurring platform fees and a potential token revenue share, but key commercial terms remain unresolved.

Firebrick Pharma is escalating Nasodine’s US push from online sales into retail pharmacies while its September-quarter cash balance fell to A$875,000. The company reported a A$398,000 operating cash outflow and estimated 2.2 quarters of funding at the current rate.